Provided by Tiger Fintech (Singapore) Pte. Ltd.

Immunic, Inc.

1.15
+0.03002.68%
Post-market: 1.13-0.0200-1.74%17:13 EDT
Volume:534.22K
Turnover:608.67K
Market Cap:103.59M
PE:-1.02
High:1.17
Open:1.12
Low:1.10
Close:1.12
Loading ...

Press Release: Immunic Highlights 2024 Accomplishments and Upcoming Milestones

Dow Jones
·
07 Jan

Winter 2024 Investor Summit Virtual: Q4 Presentations Now Available for On-Demand Viewing

ACCESSWIRE
·
04 Dec 2024

Immunic, Inc. to Participate in Investor Conference in December

PR Newswire
·
26 Nov 2024

Immunic’s Promising Pipeline Progress and Stable Financials Justify Buy Rating

TIPRANKS
·
26 Nov 2024

Immunic, Inc. : H.c. Wainwright Initiates Coverage With Buy Rating

THOMSON REUTERS
·
25 Nov 2024

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Adaptimmune Therapeutics (ADAP), Fulcrum Therapeutics (FULC) and Immunic (IMUX)

TIPRANKS
·
19 Nov 2024

Insider Buys Additional US$100k In Immunic Stock

Simply Wall St.
·
15 Nov 2024

Immunic announces publication of IMU-856 data

TipRanks
·
14 Nov 2024

Immunic Announces Publication of Data From Phase 1/1B Clinical Trial of Imu-856 in the Peer Reviewed Journal, the Lancet Gastroenterology & Hepatology

THOMSON REUTERS
·
13 Nov 2024

Immunic Announces Publication of Data From Phase 1/1b Clinical Trial of IMU-856 in the Peer Reviewed Journal, The Lancet Gastroenterology & Hepatology

PR Newswire
·
13 Nov 2024

Optimistic Buy Rating for Immunic Driven by Promising Trials and Market Opportunities for VidoCa

TIPRANKS
·
11 Nov 2024

Immunic Inc (IMUX) Q3 2024 Earnings Call Highlights: Strategic Progress Amid Financial Challenges

GuruFocus.com
·
09 Nov 2024

Immunic, Inc. Advances MS Trials Amid Financial Update

TIPRANKS
·
08 Nov 2024

Immunic Inc reports results for the quarter ended in September 30 - Earnings Summary

Reuters
·
07 Nov 2024

Immunic reports Q3 EPS (24c), consensus (22c)

TIPRANKS
·
07 Nov 2024

Immunic: Q3 Earnings Snapshot

Associated Press Finance
·
07 Nov 2024